Multiple System Atrophy clinical trials at UC Irvine

2 in progress, 0 open to eligible people

Showing trials for

  • GDNF Gene Therapy for Multiple System Atrophy

    Sorry, in progress, not accepting new patients

    The objective of this randomized, double-blinded, placebo-controlled Phase 1 investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a possible or probable diagnosis of Multiple System Atrophy.

    Irvine, California and other locations

  • Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

    Sorry, in progress, not accepting new patients

    The objective of this study is to describe disease progression in study participants diagnosed with early Parkinson's Disease or Multiple System Atrophy - Parkinsonian Type up to 18 months as delineated by clinical and biochemical parameters.

    Irvine, California and other locations

Last updated: